CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, California.

Company Data

Name CERo Therapeutics Holdings, Inc. - Warrants

Company CERo Therapeutics Holdings, Inc.

Symbol CEROW

Website https://www.cero.bio

Primary Exchange

NASDAQ

ISIN US71902K1135

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Christopher B. Ehrlich

Country United States of America

Currency USD

Employees 0,0 T

Address 201 Haskins Way, 94080 South San Francisco

ID Changes

Date	From	To
15.02.2024	PBAXW	CEROW

Ticker Symbols

Name	Symbol
NASDAQ	CEROW

More Shares

Investors who hold CERo Therapeutics Holdings, Inc. - Warrants also have the following shares in their portfolio:

AMUNDI S.F. - DIVERSIFIED SHORT-TERM BOND - H EUR AD (D) ETF

WASTE MGMT 20/50 Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog